After-hours movers: Ford, Intel, Deckers Brands, and more Oct 23, 2025 04:39PM
Qualigen partners with BitGo for $30 million crypto treasury allocation Oct 23, 2025 04:08PM
Qualigen Therapeutics Launches C10 Cryptocurrency Asset Treasury (DAT) Purchases Oct 13, 2025 05:09AM
Faraday Future signs deposit deal for 1,000 vehicles with ZEVO Oct 13, 2025 05:08AM
Qualigen Therapeutics appoints new executives and board members Oct 7, 2025 05:43AM


Sep 30, 2025 07:08AM Qualigen closes $41 million PIPE led by Faraday Future for crypto pivot
Sep 30, 2025 06:00AM Faraday Future completes $41 million investment in Qualigen Therapeutics
Jul 28, 2025 05:23PM Qualigen Therapeutics regains NASDAQ compliance with $4.5 million funding
Jul 28, 2025 12:42PM Qualigen Therapeutics raises $4.5 million in private placement
Jul 16, 2025 08:04AM Qualigen receives patents for QN-302 drug in 25 countries
May 19, 2025 05:27PM Qualigen Therapeutics (QLGN) receives Nasdaq deficiency notice after delayed 10-Q
Apr 1, 2025 08:00AM Qualigen Therapeutics (QLGN) enters non-binding MOU to acquire Marizyme
Dec 5, 2024 09:00AM Qualigen Therapeutics (QLGN) Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
Nov 19, 2024 09:01AM Qualigen Therapeutics (QLGN) Announces $4.5M Convertible Preferred Shares Offering
Oct 24, 2024 05:08PM Qualigen Therapeutics (QLGN) Files for 14M Share and Warrant Offering
Sep 26, 2024 05:17PM Qualigen Therapeutics (QLGN) Announces management changes
Sep 20, 2024 09:01AM Qualigen Therapeutics (QLGN) Received Extension from Nasdaq Hearings Panel
Sep 5, 2024 09:00AM Qualigen Therapeutics (QLGN) Prices 14.72M Share Offering at $0.13/sh